Aster DM Healthcare Receives NCLT Order Approving Scheme of Amalgamation

Aster DM Healthcare Receives NCLT Order Approving Scheme of Amalgamation

Aster DM Healthcare Receives NCLT Order Approving Scheme of Amalgamation​

Aster DM Healthcare Limited has received the certified true copy of the order passed by the National Company Law Tribunal (NCLT), Hyderabad Bench, approving the Scheme of Amalgamation between Quality Care India Limited and Aster DM Healthcare Limited.

The approval relates to a Scheme of Amalgamation between Quality Care India Limited (QCIL/Transferor Company) and Aster DM Healthcare Limited (Aster DM/Transferee Company). This transaction was sanctioned by the NCLT, Hyderabad Bench.

The certified true copy of the order approving the scheme was received on June 23, 2026.

According to the details of the Scheme, QCIL will be dissolved without winding up upon its completion. The Scheme is set to become effective after the respective companies file the certified copy of the NCLT order with the Registrar of Companies and satisfy other conditions mentioned within the scheme. Aster DM Healthcare Limited confirmed that it will inform the Stock Exchanges regarding the Effective Date in due course.

ASTERDM Stock Price Movement​

Today, Aster DM Healthcare Limited shares edged higher to settle at ₹769.7 after a positive close, recording a 0.54% gain. The stock was actively traded in the market today, with 648056 shares passing through.
 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.

Back
Top